Itasu Ninomiya

Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.

Yutaka Yonemura, Itasu Ninomiya, A Yamaguchi et al. · PubMed · 1991 · 336 citations

Tumor Biology, Gastrointestinal Oncology, Medicine +12

Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination

Takahisa Yamaguchi, Sachio Fushida, Yasuhiko Yamamoto et al. · Gastric Cancer · 2015 · 273 citations · Full text

Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer.

Yutaka Yonemura, Yoshio Endou, K Kimura et al. · PubMed · 2000 · 182 citations

Tumor Biology, Inverse Expression, Gastrointestinal Oncology +12

Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: Randomized controlled study

Takashi Fujimura, Yutaka Yonemura, K Muraoka et al. · World Journal of Surgery · 1994 · 157 citations

Expression of C-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for C-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma

Yutaka Yonemura, Itasu Ninomiya, Shigekazu Ohoyama et al. · Cancer · 1991 · 150 citations

C-erbb-2 Protein, Immunology, Gastroenterology +17